
Our team consists of seasoned professionals specializing in respiratory disorders, ensuring that your project benefits from years of cumulative knowledge and experience.
We adhere to stringent quality control protocols and GLP principles, guaranteeing that our respiratory preclinical studies meet the highest scientific and regulatory benchmarks.
KCI provides a full suite of respiratory CRO services, from disease modeling to toxicology testing, enabling a seamless pathway from discovery to clinical development.
We focus on your unique needs, offering tailored solutions that address specific requirements, timelines, and objectives in your respiratory drug development projects.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china